Infant Bacterial Therapeutics AB (publ) IBT-B.ST Stock
83 SEK
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
1.12B SEK
LOW - HIGH [24H]
80.6
-
84 SEK
VOLUME [24H]
988 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-9.95 SEK
Infant Bacterial Therapeutics AB (publ) Price Chart
Infant Bacterial Therapeutics AB (publ) IBT-B.ST Financial and Trading Overview
Contents
| Infant Bacterial Therapeutics AB (publ) stock price | 83 SEK |
| Previous Close | 46.5 SEK |
| Open | 46.5 SEK |
| Bid | 44.1 SEK x 0 |
| Ask | 45.9 SEK x 0 |
| Day's Range | 43.8 - 46.5 SEK |
| 52 Week Range | 41.3 - 70 SEK |
| Volume | 896 SEK |
| Avg. Volume | 5.57K SEK |
| Market Cap | 493.95M SEK |
| Beta (5Y Monthly) | 1.059003 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.95 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 300 SEK |
IBT-B.ST Valuation Measures
| Enterprise Value | 215.34M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.5973282 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Infant Bacterial Therapeutics AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.059003 |
| 52-Week Change | -25.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 70 SEK |
| 52 Week Low | 41.3 SEK |
| 50-Day Moving Average | 46.65 SEK |
| 200-Day Moving Average | 53.66 SEK |
IBT-B.ST Share Statistics
| Avg. Volume (3 month) | 5.57K SEK |
| Avg. Daily Volume (10-Days) | 3.46K SEK |
| Shares Outstanding | 10.85M |
| Float | 9.91M |
| Short Ratio | N/A |
| % Held by Insiders | 8.15% |
| % Held by Institutions | 30.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.94% |
| Return on Equity (ttm) | -20.054% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.001 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -68718000 SEK |
| Diluted EPS (ttm) | -6.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 306.68M SEK |
| Total Cash Per Share (mrq) | 27.32 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 13.22 |
| Book Value Per Share (mrq) | 27.546 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -103499000 SEK |
| Levered Free Cash Flow (ttm) | -53194248 SEK |
Profile of Infant Bacterial Therapeutics AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Bryggargatan 10 |
| ZIP | 111 21 |
| Phone | 46 7 62 19 37 38 |
| Website | https://www.ibtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe disease in infants. The company was incorporated in 2011 and is based in Stockholm, Sweden.
Q&A For Infant Bacterial Therapeutics AB (publ) Stock
What is a current IBT-B.ST stock price?
Infant Bacterial Therapeutics AB (publ) IBT-B.ST stock price today per share is 83 SEK.
How to purchase Infant Bacterial Therapeutics AB (publ) stock?
You can buy IBT-B.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Infant Bacterial Therapeutics AB (publ)?
The stock symbol or ticker of Infant Bacterial Therapeutics AB (publ) is IBT-B.ST.
Which industry does the Infant Bacterial Therapeutics AB (publ) company belong to?
The Infant Bacterial Therapeutics AB (publ) industry is Biotechnology.
How many shares does Infant Bacterial Therapeutics AB (publ) have in circulation?
The max supply of Infant Bacterial Therapeutics AB (publ) shares is 13.47M.
What is Infant Bacterial Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?
Infant Bacterial Therapeutics AB (publ) PE Ratio is now.
What was Infant Bacterial Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?
Infant Bacterial Therapeutics AB (publ) EPS is -9.95 SEK over the trailing 12 months.
Which sector does the Infant Bacterial Therapeutics AB (publ) company belong to?
The Infant Bacterial Therapeutics AB (publ) sector is Healthcare.
Infant Bacterial Therapeutics AB (publ) IBT-B.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1196.96 SEK 116.84 USD |
-0.26
|
— — | — — | — — | — - | — — |
| OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 517.93 ISK 3.81 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 349.16 DKK 51.19 USD |
-0.69
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 596.42 SEK 58.22 USD |
-0.19
|
— — | — — | — — | — - | — — |
| OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 435.1 SEK 42.47 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 349.01 EUR 381.52 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5132.25 SEK 500.97 USD |
+0.49
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}